Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 6012 participants.
Also called NCT02311231
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 6,012 participants
- Registry
-
NCT02311231
-
- Other papers using this trial's data
- Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction
- Bivalirudin versus Heparin Monotherapy in Myocardial Infarction
- Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction-Outcomes at two years
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Sweden
- Registry status
- Completed
Technical summary
Registry record NCT02311231. Randomized; no masking; primary purpose treatment. Start 2014-06 (registry gives no type); primary completion 2017-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART
- Acronym
- VALIDATE
- Condition
- ST-segment Elevation Myocardial Infarction
- Condition
- Non ST-segment Elevation Myocardial Infarction
- Intervention (Drug)
- bivalirudin
- Intervention (Drug)
- Heparin
- Lead sponsor
- Uppsala University
- Collaborator
- Lund University
Record details
- Record id
cardio:ct-nct02311231- Content hash
776326987c1229c4cea346a75cdabe8eca0dc76c002450e4e80d4ebadfc8beeb